In a memo from Dr Walford to Dr Fowler, Dr Walford flagged that Travenol (Hyland) were planning a symposium in early 1983 to launch a reduced hepatitis risk product.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Viral Inactivation
Key Person(s)
Dr Diana Walford